Home › NDC Lookup › Labelers › Antares Pharma, Inc.

Antares Pharma, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 18657 (Antares Pharma, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

1
Package NDCs
1
Products
1
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
1
With NADAC pricing

Portfolio

Top ingredients
Hyaluronidase 1
By dosage form
INJECTION, SOLUTION 1

Browse records — 1 product

Drug / product Billing NDC NADAC / unit Status
HYLENEX Recombinant Hyaluronidase 150 [USP'U]/mL INJECTION, SOLUTION Antares · NDC 18657-0117-04 · J3473 · 4 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01) 18657-0117-04 $53.705 /unit · NADAC On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.